Encure Bio-SWATI-AI for CVD drug discovery

 SWATI‑AI is Encure Bio’s end‑to‑end cardio‑native AI platform that designs and de‑risks new drugs and delivery systems for cardiovascular disease. It fuses multi‑omics‑rich human cardiac datasets, organoid‑based validation, and generative AI with quantum‑informed modeling and advanced nanoengineering to discover novel targets, optimize chemistry, and create innovative organ‑targeted drug delivery systems while predicting safety and efficacy long before clinical trials